Enanta PharmaceuticalsENTA 
$6.287.17%24h
7.17%24h
Global rank18379
Market cap$131.69M
Change 7d4.67%
YTD Performance-32.62%
SP500 benchmarkUnderperform
P/E-0.98
P/S1.66
Revenue$79.20M
Earnings-$133.82M
Dividend yield-
Main Sector
Healthcare
Category
Enanta Pharmaceuticals ENTA Total Debt
ENTA Total Debt in 2022: $21.24M
According to Enanta Pharmaceuticals latest financial reports the total debt is $21.24M, an decrease of -5.07% to 2022. At the end of 2022 company had $22.37M total debt. This figure represents the debts and financial obligations that Enanta Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Enanta Pharmaceuticals ENTA Total Debt History from 2023 to 2022
-
Value:-
ENTA Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $21.24M | -5.07% |
| 2022 | $22.37M | 1886.86% |
| 2021 | $1.13M | -70.66% |
| 2020 | $3.84M | 1819.00% |
| 2019 | $200.00K | -31.74% |
| 2018 | $293.00K | - |
View the Top Total Debt Stocks 
